Literature DB >> 26304514

Does difficulty functioning in the surrogate role equate to vulnerability in critical illness research? Use of path analysis to examine the relationship between difficulty providing substituted judgment and receptivity to critical illness research participation.

Brian R Clarridge1, Dragana Bolcic-Jankovic1, Jessica LeBlanc1, Rumel S Mahmood1, Carie R Kennedy2, Bradley D Freeman3.   

Abstract

PURPOSE: Individuals who struggle to provide substitute judgment for the critically ill often find it challenging to engage in decision making for therapeutic interventions. Although essential to the conduct of research, how these individuals respond to requests for clinical trial participation is poorly understood.
METHODS: Survey data collected to examine surrogate attitudes toward research provided the conceptual framework to explore influences on decision making. Path analysis was used to derive the final model (nonlatent, fully recursive, 1 indicator/variable).
RESULTS: Surrogates with list-wise complete records (406) were analyzed. The following variables were not retained in the final model: education, income, religiosity, decision-making experience, discussion of patient's wishes, number of individuals assisting with decision making, trust in care providers, difficulty making decisions, and responsibility for decision making. Being white and having experience making treatment decisions for the patient during the current intensive care unit encounter affected the likelihood the surrogate would permit participation in research positively (parameter estimates, 0.281 and 0.06, respectively). No variable reflecting difficulty functioning in the surrogate role was associated with permitting research participation.
CONCLUSIONS: We were unable to demonstrate a relationship between perceived difficulty in decision making in the surrogate role and receptivity to clinical trial participation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biospecimen; Clinical research; Critical illness; Path analysis; Substituted judgment; Surrogate decision maker

Mesh:

Year:  2015        PMID: 26304514      PMCID: PMC4628890          DOI: 10.1016/j.jcrc.2015.07.016

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  26 in total

1.  Safeguarding patients in clinical trials with high mortality rates.

Authors:  B D Freeman; R L Danner; S M Banks; C Natanson
Journal:  Am J Respir Crit Care Med       Date:  2001-07-15       Impact factor: 21.405

2.  Why substitute decision makers provide or decline consent for ICU research studies: a questionnaire study.

Authors:  Sangeeta Mehta; Friederike Quittnat Pelletier; Maedean Brown; Cheryl Ethier; David Wells; Lisa Burry; Rod MacDonald
Journal:  Intensive Care Med       Date:  2011-11-26       Impact factor: 17.440

3.  The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations.

Authors:  John M Luce; Deborah J Cook; Thomas R Martin; Derek C Angus; Homer A Boushey; J Randall Curtis; John E Heffner; Paul N Lanken; Mitchell M Levy; Paula Y Polite; Graeme M Rocker; Robert D Truog
Journal:  Am J Respir Crit Care Med       Date:  2004-12-15       Impact factor: 21.405

Review 4.  Systematic review: the effect on surrogates of making treatment decisions for others.

Authors:  David Wendler; Annette Rid
Journal:  Ann Intern Med       Date:  2011-03-01       Impact factor: 25.391

5.  Exploring determinants of surrogate decision-maker confidence: an example from the ICU.

Authors:  Dragana Bolcic-Jankovic; Brian R Clarridge; Jessica L LeBlanc; Rumel S Mahmood; Anthony M Roman; Bradley D Freeman
Journal:  J Empir Res Hum Res Ethics       Date:  2014-08-07       Impact factor: 1.742

6.  Risk of post-traumatic stress symptoms in family members of intensive care unit patients.

Authors:  Elie Azoulay; Frédéric Pochard; Nancy Kentish-Barnes; Sylvie Chevret; Jérôme Aboab; Christophe Adrie; Djilali Annane; Gérard Bleichner; Pierre Edouard Bollaert; Michael Darmon; Thomas Fassier; Richard Galliot; Maité Garrouste-Orgeas; Cyril Goulenok; Dany Goldgran-Toledano; Jan Hayon; Mercé Jourdain; Michel Kaidomar; Christian Laplace; Jérôme Larché; Jérôme Liotier; Laurent Papazian; Catherine Poisson; Jean Reignier; Fayçal Saidi; Benoît Schlemmer
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

7.  Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity.

Authors:  F Pochard; E Azoulay; S Chevret; F Lemaire; P Hubert; P Canoui; M Grassin; R Zittoun; J R le Gall; J F Dhainaut; B Schlemmer
Journal:  Crit Care Med       Date:  2001-10       Impact factor: 7.598

8.  Genetic research and testing in critical care: surrogates' perspective.

Authors:  Bradley D Freeman; Carie R Kennedy; Craig M Coopersmith; Barbara A Zehnbauer; Timothy G Buchman
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

9.  Reasons for nonenrollment in a clinical trial of acute lung injury.

Authors:  Andrea E Glassberg; John M Luce; Michael A Matthay
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

10.  Patients' views on identifiability of samples and informed consent for genetic research.

Authors:  Sara Chandros Hull; Richard R Sharp; Jeffrey R Botkin; Mark Brown; Mark Hughes; Jeremy Sugarman; Debra Schwinn; Pamela Sankar; Dragana Bolcic-Jankovic; Brian R Clarridge; Benjamin S Wilfond
Journal:  Am J Bioeth       Date:  2008-10       Impact factor: 11.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.